CRYβB2 alters cell adhesion to promote invasion in a triple-negative breast cancer cell line

Abstract Objective African American women with breast cancer experience disproportionately poor survival outcomes, primarily due to the high prevalence of the deadliest subtype; triple-negative breast cancer (TNBC). The CRYβB2 gene is upregulated in tumors from African American patients across all b...

Full description

Saved in:
Bibliographic Details
Main Authors: Amr A. Waly, London Harper, Jodie M. Fleming, Lindsey M. Costantini
Format: Article
Language:English
Published: BMC 2025-01-01
Series:BMC Research Notes
Subjects:
Online Access:https://doi.org/10.1186/s13104-025-07090-w
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832586089463808000
author Amr A. Waly
London Harper
Jodie M. Fleming
Lindsey M. Costantini
author_facet Amr A. Waly
London Harper
Jodie M. Fleming
Lindsey M. Costantini
author_sort Amr A. Waly
collection DOAJ
description Abstract Objective African American women with breast cancer experience disproportionately poor survival outcomes, primarily due to the high prevalence of the deadliest subtype; triple-negative breast cancer (TNBC). The CRYβB2 gene is upregulated in tumors from African American patients across all breast cancer subtypes, including TNBC, and is associated with worse survival rates. This study investigated the effect of CRYβB2 on the invasion of TNBC cells and the underlying mechanisms contributing to this phenotype. Results We utilized the SUM159 cells with stable CRYβB2 overexpression in a 3D-culture tumor spheroids model in our investigation. A quantitative 3D invasion assay demonstrated that CRYβB2 overexpression significantly enhanced invasion (median invasion %; SUM159 = 0.14 and SUM159 + CRYβB2 = 0.33). RNA sequencing analysis indicated that CRYβB2 overexpression modulated cell-cell adhesion and extracellular matrix organization pathways, which are critical to invasion of cancer cells. Specifically, CRYβB2 suppressed the expression of key cell-cell adhesion genes known as clustered protocadherins and promoted the expression of PCDH7, a nonclustered protocadherin with known oncogenic roles in various cancers. Notably, the knockout of PCDH7 diminished the invasive capacity induced by CRYβB2 (median invasion %; SUM159 = 0.093, SUM159 + CRYβB2 = 0.184 and SUM159 + CRYβB2/PCDH7−/−=0.082). These findings provide a novel link between a previously identified differentially expressed gene, CRYβB2, in driving breast cancer phenotypes by modulating a class of adhesion proteins.
format Article
id doaj-art-d047f23873d941a6bd15ad0be693d896
institution Kabale University
issn 1756-0500
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series BMC Research Notes
spelling doaj-art-d047f23873d941a6bd15ad0be693d8962025-01-26T12:13:24ZengBMCBMC Research Notes1756-05002025-01-011811910.1186/s13104-025-07090-wCRYβB2 alters cell adhesion to promote invasion in a triple-negative breast cancer cell lineAmr A. Waly0London Harper1Jodie M. Fleming2Lindsey M. Costantini3Biological and Biomedical Sciences Department, University of North Carolina Central UniversityBiological and Biomedical Sciences Department, University of North Carolina Central UniversityBiological and Biomedical Sciences Department, University of North Carolina Central UniversityBiological and Biomedical Sciences Department, University of North Carolina Central UniversityAbstract Objective African American women with breast cancer experience disproportionately poor survival outcomes, primarily due to the high prevalence of the deadliest subtype; triple-negative breast cancer (TNBC). The CRYβB2 gene is upregulated in tumors from African American patients across all breast cancer subtypes, including TNBC, and is associated with worse survival rates. This study investigated the effect of CRYβB2 on the invasion of TNBC cells and the underlying mechanisms contributing to this phenotype. Results We utilized the SUM159 cells with stable CRYβB2 overexpression in a 3D-culture tumor spheroids model in our investigation. A quantitative 3D invasion assay demonstrated that CRYβB2 overexpression significantly enhanced invasion (median invasion %; SUM159 = 0.14 and SUM159 + CRYβB2 = 0.33). RNA sequencing analysis indicated that CRYβB2 overexpression modulated cell-cell adhesion and extracellular matrix organization pathways, which are critical to invasion of cancer cells. Specifically, CRYβB2 suppressed the expression of key cell-cell adhesion genes known as clustered protocadherins and promoted the expression of PCDH7, a nonclustered protocadherin with known oncogenic roles in various cancers. Notably, the knockout of PCDH7 diminished the invasive capacity induced by CRYβB2 (median invasion %; SUM159 = 0.093, SUM159 + CRYβB2 = 0.184 and SUM159 + CRYβB2/PCDH7−/−=0.082). These findings provide a novel link between a previously identified differentially expressed gene, CRYβB2, in driving breast cancer phenotypes by modulating a class of adhesion proteins.https://doi.org/10.1186/s13104-025-07090-wCancer disparitiesTriple negative breast cancerCRYβB2InvasionProtocadherins
spellingShingle Amr A. Waly
London Harper
Jodie M. Fleming
Lindsey M. Costantini
CRYβB2 alters cell adhesion to promote invasion in a triple-negative breast cancer cell line
BMC Research Notes
Cancer disparities
Triple negative breast cancer
CRYβB2
Invasion
Protocadherins
title CRYβB2 alters cell adhesion to promote invasion in a triple-negative breast cancer cell line
title_full CRYβB2 alters cell adhesion to promote invasion in a triple-negative breast cancer cell line
title_fullStr CRYβB2 alters cell adhesion to promote invasion in a triple-negative breast cancer cell line
title_full_unstemmed CRYβB2 alters cell adhesion to promote invasion in a triple-negative breast cancer cell line
title_short CRYβB2 alters cell adhesion to promote invasion in a triple-negative breast cancer cell line
title_sort cryβb2 alters cell adhesion to promote invasion in a triple negative breast cancer cell line
topic Cancer disparities
Triple negative breast cancer
CRYβB2
Invasion
Protocadherins
url https://doi.org/10.1186/s13104-025-07090-w
work_keys_str_mv AT amrawaly crybb2alterscelladhesiontopromoteinvasioninatriplenegativebreastcancercellline
AT londonharper crybb2alterscelladhesiontopromoteinvasioninatriplenegativebreastcancercellline
AT jodiemfleming crybb2alterscelladhesiontopromoteinvasioninatriplenegativebreastcancercellline
AT lindseymcostantini crybb2alterscelladhesiontopromoteinvasioninatriplenegativebreastcancercellline